August 20, 2014
Nature article: Scale up the supply of experimental Ebola drugs
Estimates of the probable impact of the outbreak show that existing stocks of potentially useful medicines are insufficient, and Oliver comments on the likelihood that the current outbreak may speed the development of a drug or vaccine, but may also hamper scaling up production and distribution.
Read the full article, including supporting information, on the probable levels of exposure mentioned in the scientific literature.
As well as a customizable spreadsheet constructed by SEEG that calculates the total number of people that might require treatment for a given ebola outbreak.